AIC
NVO

Ameritas Investment Company’s Novo Nordisk NVO Stock Holding History

Ameritas Investment Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6,344
Closed -$214K – 1622
2021
Q1 		$214K Buy
+6,344
New +$226K 0.02% 566
2020
Q2 		– Sell
-7,200
Closed -$216K – 1166
2020
Q1 		$216K Buy
7,200
+4,462
+163% +$133K 0.03% 332
2019
Q4 		$79K Hold
2,738
– – 0.02% 508
2019
Q3 		$71K Buy
+2,738
New +$69.2K 0.01% 576
2019
Q2 		– Sell
-2,646
Closed -$69K – 646
2019
Q1 		$69K Buy
+2,646
New +$65K 0.01% 397

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Ameritas Investment Company's NVO Position: Q2 2021 in Review

Ameritas Investment Company sold out of Novo Nordisk (NVO) in Q2 2021, closing a stake of 6,344 shares — an estimated $214K sold.

Ameritas Investment Company first reported a position in NVO in Q1 2019 and held it in 5 quarters. The position peaked at $216K in Q1 2020. 736 funds tracked by Wall St. Rank hold NVO as of Q2 2021.

  • Ameritas Investment Company reported no remaining Novo Nordisk position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 6,344 Novo Nordisk shares in Q2 2021, an estimated $214K.
  • Ameritas Investment Company first reported a position in Novo Nordisk in Q1 2019 and held it in 5 quarters.
  • Ameritas Investment Company's Novo Nordisk position peaked at $216K in Q1 2020.
  • 736 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.